AGIOS PHARMACEUTICALS, INC. Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for February 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 28 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | M | 47.33 | 2,200 | 104,126 | 6,800 | |
Feb 28 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Buy | M | 47.33 | 2,200 | 104,126 | 2,200 | 0 to 2.2 K |
Feb 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 72,950 | |
Feb 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 78.63 | 2,050 | 161,192 | 0 | 2.1 K to 0 (-100.00 %) |
Feb 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 0.00 | 2,370 | 0 | 2,370 | |
Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 0.00 | 2,800 | 0 | 2,800 | |
Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 77.70 | 9,480 | 736,596 | 9,480 | |
Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 0.00 | 8,250 | 0 | 8,250 | |
Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 77.70 | 33,000 | 2,564,100 | 33,000 | |
Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 0.00 | 8,250 | 0 | 8,250 | |
Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 77.70 | 33,000 | 2,564,100 | 33,000 | |
Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | A | 0.00 | 8,250 | 0 | 8,250 | |
Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | A | 77.70 | 33,000 | 2,564,100 | 33,000 | |
Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | A | 0.00 | 24,375 | 0 | 24,375 | |
Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | A | 77.70 | 97,500 | 7,575,750 | 97,500 | |
Feb 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 2,936 | 26,571 | 31,154 | |
Feb 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 64 | 30 | 1,803 | |
Feb 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 78.03 | 400 | 31,212 | 53,059 | 53.5 K to 53.1 K (-0.75 %) |
Feb 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 76.76 | 701 | 53,809 | 53,459 | 54.2 K to 53.5 K (-1.29 %) |
Feb 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 75.70 | 1,100 | 83,270 | 54,160 | 55.3 K to 54.2 K (-1.99 %) |
Feb 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 74.89 | 799 | 59,837 | 55,260 | 56.1 K to 55.3 K (-1.43 %) |
Feb 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 2,936 | 26,571 | 56,059 | 53.1 K to 56.1 K (+5.53 %) |
Feb 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 64 | 30 | 53,123 | 53.1 K to 53.1 K (+0.12 %) |
Feb 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 13,000 | 3,933 | 104,567 | |
Feb 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 79.23 | 4,460 | 353,366 | 0 | 4.5 K to 0 (-100.00 %) |
Feb 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 78.50 | 8,540 | 670,390 | 4,460 | 13 K to 4.5 K (-65.69 %) |
Feb 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 13,000 | 3,933 | 13,000 | 0 to 13 K |